Cargando…

Long-Term Outcomes of Longitudinal Efficacy Study With Tolvaptan in ADPKD

INTRODUCTION: The effects of long-term and uninterrupted tolvaptan treatment on autosomal dominant polycystic kidney disease (ADPKD) are unclear. Therefore, a more than 3-year continuous treatment study was performed. METHODS: From the Kyorin University cohort, 299 patients were surveyed and 179 pat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Higashihara, Eiji, Nutahara, Kikuo, Itoh, Masayuki, Okegawa, Takatsugu, Tambo, Mistuhiro, Yamaguchi, Tsuyoshi, Nakamura, Yu, Taguchi, Satoru, Kaname, Shinya, Yokoyama, Kenichi, Yoshioka, Tatsuya, Fukuhara, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8820994/ https://www.ncbi.nlm.nih.gov/pubmed/35155866 http://dx.doi.org/10.1016/j.ekir.2021.11.034

Ejemplares similares

Estimation of Changes in Kidney Volume Growth Rate in ADPKD
por: Higashihara, Eiji, et al.
Publicado: (2020)

Age- and height-adjusted total kidney volume growth rate in autosomal dominant polycystic kidney diseases
por: Higashihara, Eiji, et al.
Publicado: (2018)

Predictors of septic shock in obstructive acute pyelonephritis
por: Tambo, Mitsuhiro, et al.
Publicado: (2013)

Distinguishing testicular torsion from torsion of the appendix testis by clinical features and signs in patients with acute scrotum
por: Fujita, Naoyuki, et al.
Publicado: (2017)

Serum level and immunohistochemical expression of vascular endothelial growth factor for the prediction of postoperative recurrence in renal cell carcinoma
por: Fujita, Naoyuki, et al.
Publicado: (2014)

A potentially crucial role of the PKD1 C-terminal tail in renal prognosis
por: Higashihara, Eiji, et al.
Publicado: (2017)

Epidermal Growth Factor Receptor Status in Circulating Tumor Cells as a Predictive Biomarker of Sensitivity in Castration-Resistant Prostate Cancer Patients Treated with Docetaxel Chemotherapy
por: Okegawa, Takatsugu, et al.
Publicado: (2016)

Kidney volume and function in autosomal dominant polycystic kidney disease
por: Higashihara, Eiji, et al.
Publicado: (2013)

Vesicoenteric Fistula Arising from an Adenocarcinoma of Ectopic Pancreatic Tissue in a Meckel Diverticulum
por: Fujita, Naoyuki, et al.
Publicado: (2018)

Presepsin and procalcitonin as predictors of sepsis based on the new Sepsis-3 definitions in obstructive acute pyelonephritis
por: Tambo, Mitsuhiro, et al.
Publicado: (2020)

Prognostic significance of the albumin-to-globulin ratio for upper tract urothelial carcinoma
por: Omura, Shota, et al.
Publicado: (2020)

Potential effect of tolvaptan on polycystic liver disease for patients with ADPKD meeting the Japanese criteria of tolvaptan use
por: Mizuno, Hiroki, et al.
Publicado: (2022)

Laparoscopic radical prostatectomy versus robot-assisted radical prostatectomy: comparison of oncological outcomes at a single center
por: Okegawa, Takatsugu, et al.
Publicado: (2020)

Effects on Depression and Anxiety After Mid-Urethral Sling Surgery for Female Stress Urinary Incontinence
por: Kinjo, Manami, et al.
Publicado: (2020)

Clinical validity of non-contrast-enhanced VI-RADS: prospective study using 3-T MRI with high-gradient magnetic field
por: Watanabe, Masanaka, et al.
Publicado: (2022)

Tolvaptan in ADPKD Patients With Very Low Kidney Function
por: Torres, Vicente E., et al.
Publicado: (2021)

Pigmented median raphe cyst of the penis that developed after middle age without infection or trauma history
por: Kii, Toshihiko, et al.
Publicado: (2021)

Laparoscopic retroperitoneal lymph node dissection versus open retroperitoneal lymph node dissection for testicular cancer: A comparison of clinical and perioperative outcomes
por: Shishido, Toshihide, et al.
Publicado: (2022)

Renal disease progression in autosomal dominant polycystic kidney disease
por: Higashihara, Eiji, et al.
Publicado: (2012)

Genomic analysis of circulating tumor cells in adenosquamous carcinoma of the prostate: a case report
por: Kitamura, Junji, et al.
Publicado: (2021)

Effect of Tolvaptan Treatment on Acid−Base Homeostasis in ADPKD Patients
por: Bargagli, Matteo, et al.
Publicado: (2021)

Pooled Data Analysis of the Long-Term Treatment Effects of Tolvaptan in ADPKD
por: Zhou, Xiaolei, et al.
Publicado: (2022)

Effects of Tolvaptan on Oxidative Stress in ADPKD: A Molecular Biological Approach
por: Rigato, Matteo, et al.
Publicado: (2022)

A Randomized Trial of Modified-Release Versus Immediate-Release Tolvaptan in ADPKD
por: Perrone, Ronald D., et al.
Publicado: (2020)

Per-Treatment Post Hoc Analysis of Clinical Trial Outcomes With Tolvaptan in ADPKD
por: Mallett, Andrew J., et al.
Publicado: (2021)

Intratumor Heterogeneity in Primary Kidney Cancer Revealed by Metabolic Profiling of Multiple Spatially Separated Samples within Tumors
por: Okegawa, Takatsugu, et al.
Publicado: (2017)

Urinary Aquaporin 2 as a Potential Indicator Predicting Tolvaptan Response in Patients With ADPKD
por: Makabe, Shiho, et al.
Publicado: (2021)

Author’s Reply to Correspondence: “Effect of Tolvaptan Treatment on Acid−Base Homeostasis in ADPKD Patients”
por: Heida, Judith E., et al.
Publicado: (2021)

Clinical Utility and Tolerability of Tolvaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
por: Raina, Rupesh, et al.
Publicado: (2022)

Does increased water intake prevent disease progression in autosomal dominant polycystic kidney disease?
por: Higashihara, Eiji, et al.
Publicado: (2014)

The Effect of Dietary Intervention on Autosomal-Dominant Polycystic Kidney Disease (ADPKD) Patients on Tolvaptan and Their Quality of Life
por: Tarabzuni, Ola
Publicado: (2022)

Interaction Between Determinants Governing Urine Volume in Patients With ADPKD on Tolvaptan and its Impact on Quality of Life
por: Todorova, Polina, et al.
Publicado: (2023)

Outcomes from the Northeast England cohort of autosomal dominant polycystic kidney disease (ADPKD) patients on tolvaptan
por: Gkekas, Eleftherios, et al.
Publicado: (2022)

Development and Validation of a Novel Recurrence Risk Stratification for Initial Non-muscle Invasive Bladder Cancer in Asia
por: Ieda, Takeshi, et al.
Publicado: (2016)

Is the light at the end of the tunnel nigh? A review of ADPKD focusing on the burden of disease and tolvaptan as a new treatment
por: Barnawi, Rashid A, et al.
Publicado: (2018)

10-Year Evaluation of Adherence and Satisfaction with Information about Tolvaptan in ADPKD: A Single-Center Pilot Study
por: Schirutschke, Holger, et al.
Publicado: (2021)

Case report: tolvaptan-associated creatine kinase elevation in two patients with autosomal dominant polycystic kidney disease (ADPKD)
por: Agraz-Pamplona, I., et al.
Publicado: (2020)

Acute hypotension induced by suction of cystic fluid containing extremely high concentrations of catecholamines during resection of giant pheochromocytoma
por: Samejima, Mio, et al.
Publicado: (2019)

Tolvaptan for the Treatment of Refractory Ascites
por: Kurosaki, Masayuki, et al.
Publicado: (2016)

Renal Transcatheter Arterial Embolization for ADPKD
por: Oda, Yasuhiro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_girh9uprt34l56p68tpd78h4vf